Dyno Therapeutics and NVIDIA collaborate on AI to accelerate the design of high-performance biological sequences
Dyno Therapeutics announced a collaboration with NVIDIA to leverage Dyno’s field-leading artificial intelligence (AI) and in vivo experimentation capabilities, along with the built-to-scale NVIDIA BioNeMo AI-powered drug design platform, to help advance biological sequence design. Everything life does is controlled by biological sequences: DNA, RNA, and proteins. The…